Enzymatic assays for 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, a promising new "nonclassical" antifolate.
Enzymatic assays for 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, a promising new "nonclassical" antifolate.
复制标题
2,4-二氨基-5-甲基-6-[(3,4,5-三甲氧基苯胺基)甲基]喹唑啉(一种有前途的新型“非经典”抗叶酸剂)的酶法测定。
DOI:
10.1002/jps.2600700737
复制
发表时间:
1981
影响因子:
3.8
通讯作者:
McCormack,JJ
中科院分区:
文献类型:
--
作者:
Heusner,JJ;McCormack,JJ
2,4‐Diamino‐5‐methyl‐6‐[(3,4,5‐trimethoxyanilino)‐methyl]quinazoline (I) is a promising new “nonclassical” antifolate. Inhibition of dihydrofolate reductase from bacterial (Lactobacillus casei) and mammalian (beef liver) sources was employed to develop useful enzymatic assays for this compound. A linear relationship was obtained by plotting the I concentration versus 1/V. The resultant standard curves maintained linearity particularly well between the 30 and 70% control range, with a correlation coefficient of 0.99 for both enzyme systems. The two enzyme systems are characterized by differences in sensitivity, stability, and day‐to‐day variation. The ID50for the beef liver reductase system was 1.6 × 10−9M(±0.3); for theL. caseisystem, it was 1.35 × 10−8M(±0.2). The apparent advantage for the beef liver enzyme was offset somewhat by its relative instability and its higher day‐to‐day variability. Studies in mice demonstrated that these assays are suitable for pharmacokinetic studiesin vivo.Such studies indicated that I has a serum t1/2of 45 min in mice; a similar serum t1/2(50 min) was estimated in studies with14C‐labeled I in position 6.